• Alexion Pharmaceuticals 2014 Annual Report cover

Alexion Pharmaceuticals 2014 Annual Report

Breakthrough Medical Innovations for Patients with Severe and Rare Disorders

The Alexion Pharmaceuticals 2014 annual report focuses on the Company’s mission to create life-transforming therapies for patients with severe, ultra-rare and life-threatening disorders. Photographs of patients receiving Soliris help to communicate the transformational nature of Alexion’s work.